CEO and President L Daniel Browne sold $96K of Revance Therapeutics, Inc.

Sold$96,285

$17.68Price

5,446Shares

−3%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Tue, Feb 19. Filed Wed, Feb 20, 4:31 PM ET, after the close. Not investment advice.